Automation is the way forward

An article in Pharmaphorum recently discussed why automating data capture is helping pharma optimise HCP engagement. A data-enriched approach enables pharma marketing teams to develop strategies which align with specific HCP preferences. This ensures they are delivering the most relevant and valuable content to HCPs using the most relevant channel. However, if this data is collected manually, it is a resource-intensive exercise, and pharma is adopting solutions that gather data automatically to overcome this challenge.

Tangent90 enable pharma to share copyright scientific content from respected medical journals which helps drive engagement with HCPs. Our solutions not only support the convenient delivery of content but also provide detailed insights into how that content is consumed, allowing pharma to optimise its ongoing HCP engagement strategy.

As a Veeva Systems Silver Technology Partner, we help pharma close the loop by feeding the data collected when sharing scientific content, such as ePrints, back into Veeva CRM. These insights help pharma build a complete picture of their target audience, enabling marketers to see what scientific content an HCP has engaged with, as well as which channels they prefer. This information is utilised by sales reps to tailor their approach to ensure they optimise each engagement opportunity. And of course, the insights offer a critical data source for pharma’s next-best action approaches.

To find out more about how Tangent90 can support you to manage your scientific content distribution, please contact us at hello@tangent90.com.

Related news

Copyright compliance

Managing compliance

With thousands of new regulatory guidelines issued every year, it’s easy for pharma to forget that something as simple as sharing copyright scientific content also requires a compliant approach. Keeping on top of these additional compliance requirements is a challenge, but there is a solution.

Pharma web portal

Portal pressure – making pharma portals work

According to an article in Pharmaphorum, pharma portals are underutilised by HCPs, with low engagement rates and reports of poor user experience. These portals are key to supporting the communication of product information. So given the importance of the information they provide, how can pharma make the portal experience more valuable for HCPs?

First party data

The first-party data opportunity

The pharma industry has embraced the digital revolution and with that the opportunity to use more readily available data. However, effective digital engagement only works if first-party data (information a company collects directly from its customers and owns) is collected and subsequently used properly.

Scroll to Top

Book A Demo

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.